GlassScriptPhysician profile
Alexander D Lee
NPI 1336209485
$1,889.99
in general payments reported to CMS, 2019-2025
11 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $27.86 · 2021: $196 · 2022: $206 · 2023: $294 · 2024: $199 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $441.34 | 2019 | |
| Medtronic, INC. | $440.26 | 2022-2025 | Symplicity G3 |
| Abbott Laboratories | $337.46 | 2021-2023 | Cardiomems |
| Shockwave Medical, INC | $185.39 | 2025 | |
| Heartflow, INC. | $158.26 | 2020-2023 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $130.00 | 2019 | |
| Abiomed | $84.28 | 2019-2024 | Impella |
| Penumbra, INC. | $35.38 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $28.33 | 2019 | |
| Zoll Circulation INC | $25.87 | 2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Pfizer INC. | $23.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.